Radius Health to Announce Third Quarter 2017 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
108
Radius Health to Announce Third Quarter 2017 Financial Results, Host Conference Call and Live Webcast on November 2, 2017

WALTHAM, Mass., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS ) announced today that it will release its third quarter 2017 financial results on Thursday, November 2, 2017. The Company will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the results and provide a company update.

Conference Call Information: Date: Thursday, November 2, 2017 Time: 4:30 p.m. ET Domestic Dial-in Number: (866) 323-7965 International Dial-in Number: (346) 406-0961 Conference ID: 96777747 Live webcast: https://edge.media-server.com/m6/p/5c3izimp

A replay of the conference call/webcast will be available from November 2, 2017 at 7:30 p.m. ET until November 9, 2017 at 6:30 p.m. ET. To access the replay, dial (855) 859-2056 for U.S. or (404) 537-3406 for International. The replay conference ID is 96777747.

The live audio webcast of the call can be accessed from the Investors section of the Company's website,  www.radiuspharm.com . A webcast replay will be also available for 14 days. The full text of the announcement and financial results will also be available on the Company's website.

About Radius Radius is a science-driven fully integrated biopharmaceutical company developing and commercializing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases. Radius' lead product, TYMLOS™ (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. Radius' Marketing Authorisation Application (MAA) for abaloparatide-SC for the treatment of postmenopausal women with osteoporosis is under regulatory review in Europe. Radius’ clinical pipeline includes an investigational abaloparatide transdermal patch for potential use in osteoporosis; the investigational drug elacestrant (RAD1901) for potential use in hormone-driven and/or hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women; and, RAD140, a non-steroidal, selective androgen receptor modulator (SARM), under investigation for potential use in hormone receptor positive breast cancer. For more information, please visit www.radiuspharm.com . 

Investor / Media Relations Contact: Alex Fudukidis Tel: (646) 942-5632 Email: alex.fudukidis@russopartnersllc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming $1000 into Wealth with Cognizant Tech Solutions

Updated Category News Views 251

Transforming Investment with Cognizant Tech Solutions Cognizant Tech Solns (NASDAQ: CTSH) has shown remarkable growth over the past two decades, significantly outperforming the market and providing substantial returns to its investors. With an average annual return of 10.38%, investors have witnessed the power of compounding in action. Currently, the company boasts a...

Continue Reading
Sesame Software Achieves SOC 2 Compliance, Ensuring Data Security for 2025

Updated Category News Views 175

Sesame Software Milestone: Achieving SOC 2 Level 1 Compliance Sesame Software, a leader in innovative data integration and backup solutions, proudly announces its successful achievement of SOC 2 Level 1 compliance. This milestone is a testament to the company's unwavering commitment to protecting customer data and maintaining the highest standards of information security...

Continue Reading
O Positiv Launches Innovative URO Boric Acid Suppository

Updated Category News Views 299

O Positiv Launches URO Boric Acid Suppository for Women's Health Boric Acid Vaginal Suppository Aims to Support Healthy Vaginal Odor and pH Levels O Positiv, a pioneering women's health brand known for challenging societal taboos, is excited to announce the launch of its newest product: the URO Boric Acid Suppository. This marks the fifth addition to their dedicated line...

Continue Reading
Urgently Faces Challenges as Nasdaq Raises Compliance Issues

Updated Category News Views 265

Urgently Confronts Nasdaq Compliance Challenges Urgently Inc. (Nasdaq: ULY), a prominent provider of digital roadside and mobility assistance solutions, has recently found itself in a challenging situation with Nasdaq. The company received a notification from The Nasdaq Stock Market LLC, indicating that it has fallen short of the minimum requirements necessary for...

Continue Reading
CenterGate Capital Successfully Transfers Mid-State Maintenance

Updated Category News Views 457

CenterGate Capital Completes Sale of Mid-State Industrial Maintenance CenterGate Capital, an established private equity investment firm, is excited to announce the successful sale of its portfolio company, Mid-State Industrial Maintenance, to ONCAP, a prominent private equity platform of Onex Corporation. This move signifies a strategic expansion in the industrial...

Continue Reading